Cullen Frost Bankers Inc. Acquires 150 Shares of Intuitive Surgical, Inc. (ISRG)

Cullen Frost Bankers Inc. lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.7% in the 3rd quarter, HoldingsChannel reports. The fund owned 4,175 shares of the medical equipment provider’s stock after buying an additional 150 shares during the quarter. Cullen Frost Bankers Inc.’s holdings in Intuitive Surgical were worth $2,396,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the company. CENTRAL TRUST Co grew its holdings in Intuitive Surgical by 26.4% during the 3rd quarter. CENTRAL TRUST Co now owns 460 shares of the medical equipment provider’s stock valued at $264,000 after purchasing an additional 96 shares in the last quarter. Wedbush Securities Inc. grew its holdings in Intuitive Surgical by 1.4% during the 2nd quarter. Wedbush Securities Inc. now owns 7,086 shares of the medical equipment provider’s stock valued at $3,391,000 after purchasing an additional 98 shares in the last quarter. Securian Asset Management Inc grew its holdings in Intuitive Surgical by 0.9% during the 2nd quarter. Securian Asset Management Inc now owns 11,795 shares of the medical equipment provider’s stock valued at $5,644,000 after purchasing an additional 100 shares in the last quarter. Sun Life Financial INC grew its holdings in Intuitive Surgical by 59.9% during the 2nd quarter. Sun Life Financial INC now owns 307 shares of the medical equipment provider’s stock valued at $147,000 after purchasing an additional 115 shares in the last quarter. Finally, Envestnet Asset Management Inc. grew its holdings in Intuitive Surgical by 2.8% during the 2nd quarter. Envestnet Asset Management Inc. now owns 4,229 shares of the medical equipment provider’s stock valued at $2,022,000 after purchasing an additional 117 shares in the last quarter. 84.14% of the stock is owned by institutional investors.

Intuitive Surgical stock opened at $521.18 on Thursday. Intuitive Surgical, Inc. has a 1 year low of $359.75 and a 1 year high of $581.12. The stock has a market capitalization of $55.60 billion, a PE ratio of 72.49, a price-to-earnings-growth ratio of 3.21 and a beta of 0.89.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, October 18th. The medical equipment provider reported $2.83 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.66 by $0.17. Intuitive Surgical had a net margin of 22.31% and a return on equity of 18.79%. The company had revenue of $920.90 million for the quarter, compared to the consensus estimate of $916.22 million. During the same period last year, the firm posted $2.77 EPS. The company’s revenue for the quarter was up 14.0% on a year-over-year basis. On average, research analysts anticipate that Intuitive Surgical, Inc. will post 9.52 earnings per share for the current year.

In related news, COO Salvatore Brogna sold 2,652 shares of the stock in a transaction dated Tuesday, September 4th. The shares were sold at an average price of $557.39, for a total value of $1,478,198.28. Following the sale, the chief operating officer now owns 2,049 shares of the company’s stock, valued at approximately $1,142,092.11. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP David J. Rosa sold 32,500 shares of the stock in a transaction dated Tuesday, October 23rd. The stock was sold at an average price of $500.86, for a total transaction of $16,277,950.00. Following the completion of the sale, the executive vice president now directly owns 44,208 shares in the company, valued at approximately $22,142,018.88. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 75,503 shares of company stock worth $38,771,530. Insiders own 2.20% of the company’s stock.

A number of research firms recently weighed in on ISRG. Piper Jaffray Companies raised their price target on shares of Intuitive Surgical from $613.00 to $625.00 and gave the company an “overweight” rating in a report on Wednesday. BidaskClub lowered shares of Intuitive Surgical from a “strong-buy” rating to a “buy” rating in a report on Tuesday, July 31st. Citigroup raised their price target on shares of Intuitive Surgical from $561.00 to $592.00 and gave the company a “buy” rating in a report on Thursday, August 2nd. Stifel Nicolaus raised their price target on shares of Intuitive Surgical from $515.00 to $600.00 and gave the company a “buy” rating in a report on Friday, July 20th. Finally, JPMorgan Chase & Co. reaffirmed an “overweight” rating and set a $575.00 price target on shares of Intuitive Surgical in a report on Friday, July 20th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and seventeen have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $554.64.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Featured Story: What are the risks of holding treasury bonds?

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply